key: cord-0875695-w7nu0ss5
authors: Lin, Yi-Tung; Chen, Pang-Yen; Su, Yu-Jang
title: Paroxysmal Supra-ventricular Ventricular Tachycardia after AstraZeneca COVID-19 Vaccine Injection
date: 2022-02-04
journal: New Microbes New Infect
DOI: 10.1016/j.nmni.2022.100965
sha: 0fccf38099aebf164b8fa21a832f8bb19488baa9
doc_id: 875695
cord_uid: w7nu0ss5

nan

A 29-year-old ear-nose-throat doctor presented to our emergency department with fever and chills for one day. He complained of palpitation, headache, chest tightness, and dry coughing after shot of Oxford/AstraZeneca COVID-19 vaccine for 1 day. He was healthy before except he ever had episode of paroxysmal supraventricular tachycardia (PSVT) when he was a child. Upon physical examination, he had a fever of up to 39 degrees Celsius, a heart rate of 241 beats per minute (BPM), respiratory rate of 18 times per minute, blood pressure: 103/76 mmHg, and saturation of oxygen via pulse oximeter was 99%. Laboratory tests revealed no leukocytosis nor elevation of cardiac enzymes. Chest X-ray was unremarkable. However, electrocardiography (ECG) showed Paroxysmal supraventricular tachycardia (Figure-1) . Intravenous adenosine 6mg administration and adequate hydration were administered. Then, the follow-up electrocardiography after 6 mg adenosine revealed sinus tachycardia (heart rate: 126 beats per minute).

After a few hours of observation, he was discharged under stable condition.

Oxford/AstraZeneca COVID-19 vaccine may lead to fever, malaise, myalgia, arthralgias, and pain over the injection site. The fever usually occurs within the first 2 days after vaccination. The incidence rate of fever is 28% of first dose J o u r n a l P r e -p r o o f and 10% aged >60 years. But no data was available for Moderna and Vaxzevria-AstraZeneca [1]. The fever causes vasodilatation and hypotension and compensation by increaing heart rate to provide higher cardiac output leading to PSVT [2] .

Other COVID-19 vaccines related arrhythmia, a US report in November 2021 describing mRNA COVID-19 vaccines happened to mean age of 15.6 ± 1.8 years inducing arrhythmia with a rate of 8% ventricular tachycardia and 3% of complete atrio-ventricular block [3] . Therefore, if a patient is known to have history of PSVT or other kinds of tachyarrhythmias, it is best policy to lower the body temperature after vaccination if fever occurred. This is the first case of PSVT caused by the Oxford/AstraZeneca COVID-19 vaccine complicated with fever. 

COVID-19 Vaccination-Associated Myocarditis in Adolescents

Role in writing: Yi-Tung Lin wrote the draft, discussed with Dr. Pang-Yen Chen

Su treated this patient, revised the text and corresponded. Figure Legends: Figure-1: Initial electrocardiography showed paroxysmal supraventricular tachycardia (PSVT), heart rate: 241 beats per minute